INNOVATIONS THAT WILL IMPACT THE FUTURE OF INTERVENTIONAL CARDIOLOGY

Sunday, March 9, 2025

12:15 PM – 1:30 PM ET

Moderator(s)

Nabil Dib, MD, MSc, FACC

Director Cardiovascular Research
Mercy Gilbert Medical Center/Dignity Health
Gilbert, Arizona, United States

Disclosure(s): Dib UltraNav Medical, LLC: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing)
Spencer B. King, III, MD, MACC, MSCAI

Professor of Medicine Emeritus
Emory University
Atlanta, Georgia, United States

Disclosure(s): No financial relationships to disclose
Ron Waksman, MD, MSCAI

Director, Cardiovascular Research and Advanced Education
MedStar Washington Hospital Center, MedStar Heart and Vascular Institute
Washington, District of Columbia, United States

Disclosure(s): Abbott Vascular: Grant/Research Support (Ongoing); Biotronik: Consultant (Ongoing), Grant/Research Support (Ongoing); Boston Scientific Corporation: Consultant (Ongoing), Grant/Research Support (Ongoing); Chiesi USA: Grant/Research Support (Ongoing)

Disclosure(s):

Nabil Dib, MD, MSc, FACC, FESC: Dib UltraNav Medical, LLC: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing)

Spencer B. King, MD, MACC, MSCAI, III: No financial relationships to disclose

Ron Waksman, MD, MSCAI: Abbott Vascular: Grant/Research Support (Ongoing); Biotronik: Consultant (Ongoing), Grant/Research Support (Ongoing); Boston Scientific Corporation: Consultant (Ongoing), Grant/Research Support (Ongoing); Chiesi USA: Grant/Research Support (Ongoing)